Single-anastomosis duodenoileal bypass as a second step after sleeve gastrectomy

Sánchez‐Pernaute, Andrés; Rubio, Miguel A.; Conde, Marina; Arrue, Emmy; Pérez-Aguirre, Elia; Torres, Antonio

doi:10.1016/j.soard.2014.06.016

Cited by 108 publications

(42 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This question will represent controversy and it will become a matter of debate. In our opinion, in case of weight regain with acceptable follow-up after the primary procedure, a single anastomosis duodeno-ileostomy (SADI) can be proposed [28].…”

Section: Discussionmentioning

confidence: 99%

Nissen Sleeve (N-Sleeve) operation: preliminary results of a pilot study

Nocca

Skalli

Boulay

et al. 2016

Surgery for Obesity and Related Diseases

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Nissen Sleeve (N-Sleeve) operation: preliminary results of a pilot study

Nocca

Skalli

Boulay

et al. 2016

Surgery for Obesity and Related Diseases

View full text Add to dashboard Cite

“…The outcomes of these revisions are in the short term acceptable but there are only few long-term results. In the case of sleeve failure, however, there are more options that include the conversion to an RYGB or into a malabsorptive procedure such as the duodenal switch or a single-anastomosis duodenal-ileale switch (181,182,183,184,185). Similar to the revisions after failed RYGB, the long-term outcome data after failed SG is also strongly limited.…”

Section: Discussionmentioning

confidence: 99%

MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass

Billeter

Herrera

Scheurlen

et al. 2018

European Journal of Endocrinology

View full text Add to dashboard Cite

Obesity and its associated comorbidities have become one of the largest challenges for health care in the near future. Conservative therapy for obesity and related comorbidities has a very high failure rate and poor long-term results. Similarly, the conservative and medical management of the majority of metabolic diseases such as type 2 diabetes mellitus are only able to slow down disease progression but have no causal effect on the disease process. Obesity surgery has evolved as a highly effective therapy for severe obesity achieving long-lasting weight loss. Furthermore, several studies have demonstrated the beneficial effects of obesity surgery on reduction of overall mortality, reduction of cardiovascular events and superior control of obesity-related diseases such as type 2 diabetes mellitus, dyslipidemia and also the non-alcoholic steatohepatitis compared to medical therapy. Based on these findings, the term 'metabolic surgery' with the focus on treating metabolic diseases independent of body weight has been coined. Of great interest are recent studies that show that even existing complications of metabolic diseases such as diabetic nephropathy or the non-alcoholic steatohepatitis can be reversed by metabolic surgery. Although metabolic surgery has proven to be a safe and effective treatment for obesity, resolution of comorbidities and enhancing quality of life, it is still uncertain and unclear, which surgical procedure is the most effective to achieve these metabolic effects. The aim of this review is to compare the effects of the two currently most widely used metabolic operations, the Roux-en-Y gastric bypass and the sleeve gastrectomy in the treatment of obesity and its related comorbidities.

show abstract

“…There are only a few descriptions of SADI-S as a primary- or second-step operation after SG in the literature [17], [18], [19], [20]. The procedure constitutes a simplification of the conventional duodenal switch.…”

Section: Discussionmentioning

confidence: 99%

“…Due to the malabsorption the described complications and secondary effects, are predominantly diarrhea and hypoalbuminemia. However surgery is described to be safe and effective [17], [18], the side effects of preserving pylorus and creating a high pressure system remain a challenging disadvantage: GERD can worsen or occur de-novo.…”

Section: Discussionmentioning

confidence: 99%

The first case report of failed single-anastomosis-duodeno-ileal bypass converted to One anastomosis gastric bypass/Mini-gastric bypass

Chiappetta

Stier

Scheffel

et al. 2017

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

HighlightsRevisional bariatric surgery will rise in the future.The established single-anastomosis-duodeno-ileal bypass with sleeve gastrectomy (SADI-S) as the restrictive part of the procedure. Due to preserved pylorus, SG has the disadvantage of a high-pressure system with de-novo or worsening of existing gastroesophageal reflux disease in the long-term.One anastomosis gastric bypass/Mini-gastric bypass (OAGB/MGB) reduces the high-pressure system of SG in a low-pressure system of OAGB/MGB.OAGB/MGB might be a simple method to rescue failed SADI-S patients.

show abstract

Single-anastomosis duodenoileal bypass as a second step after sleeve gastrectomy

Cited by 108 publications

References 20 publications

Nissen Sleeve (N-Sleeve) operation: preliminary results of a pilot study

Nissen Sleeve (N-Sleeve) operation: preliminary results of a pilot study

MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass

The first case report of failed single-anastomosis-duodeno-ileal bypass converted to One anastomosis gastric bypass/Mini-gastric bypass

Contact Info

Product

Resources

About